Gupta Shalabh K. 4
4 · Unicycive Therapeutics, Inc. · Filed Jul 30, 2025
Insider Transaction Report
Form 4
Gupta Shalabh K.
DirectorCEO
Transactions
- Award
Stock Options
2025-07-28+325,000→ 968,951 totalExercise: $4.71Exp: 2035-07-28→ Common Stock (325,000 underlying)
Footnotes (1)
- [F1]81,250 of the stock options vest on July 28, 2026 and 1/36th of the remaining options vest at the end of each successive month thereafter.